摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

propan-2-yl N-[N-[(2S)-2-[2-[1-(7-azabicyclo[2.2.1]heptan-7-yl)-2-methyl-1-oxopropan-2-yl]-5-(3,5-dimethylphenyl)-6H-thieno[2,3-b]pyrrol-4-yl]propyl]-C-(3-pyridin-4-ylpyrrolidin-1-yl)carbonimidoyl]carbamate | 667940-38-7

中文名称
——
中文别名
——
英文名称
propan-2-yl N-[N-[(2S)-2-[2-[1-(7-azabicyclo[2.2.1]heptan-7-yl)-2-methyl-1-oxopropan-2-yl]-5-(3,5-dimethylphenyl)-6H-thieno[2,3-b]pyrrol-4-yl]propyl]-C-(3-pyridin-4-ylpyrrolidin-1-yl)carbonimidoyl]carbamate
英文别名
——
propan-2-yl N-[N-[(2S)-2-[2-[1-(7-azabicyclo[2.2.1]heptan-7-yl)-2-methyl-1-oxopropan-2-yl]-5-(3,5-dimethylphenyl)-6H-thieno[2,3-b]pyrrol-4-yl]propyl]-C-(3-pyridin-4-ylpyrrolidin-1-yl)carbonimidoyl]carbamate化学式
CAS
667940-38-7
化学式
C41H52N6O3S
mdl
——
分子量
708.968
InChiKey
HBEOQECBELMPFM-JOHFNQGMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.7
  • 重原子数:
    51
  • 可旋转键数:
    11
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.51
  • 拓扑面积:
    131
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] THIENO-PYRROLE COMPOUNDS AS ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE<br/>[FR] COMPOSES DE THIENO-PYRROLE UTILISES COMME ANTAGONISTES DE L'HORMONE DE LIBERATION DE GONADOTROPHINE
    申请人:ASTRAZENECA AB
    公开号:WO2004018479A1
    公开(公告)日:2004-03-04
    The invention relates to a group of novel thieno-pyrrole compounds of Formula (I), wherein: R1, R2, R4, R5, R6, R6a, R7, R8, A and B are as defined in the specification, which are useful as gonadotrophin releasing hormone antagonists. The invention also relates to pharmaceutical formulations of said compounds, methods of treatment using said compounds and to processes for the preparation of said compounds.
    该发明涉及一组新颖的噻吩-吡咯化合物,其化学式为(I),其中:R1、R2、R4、R5、R6、R6a、R7、R8、A和B如规范中定义,这些化合物可用作促性腺激素释放激素拮抗剂。该发明还涉及所述化合物的药物配方、使用所述化合物的治疗方法以及所述化合物的制备方法。
  • Synthesis and structure–activity relationships of thieno[2,3-b]pyrroles as antagonists of the GnRH receptor
    作者:Jean Claude Arnould、Bénédicte Delouvrié、Pascal Boutron、Al G. Dossetter、Kevin M. Foote、Annie Hamon、Urs Hancox、Craig S. Harris、Mike Hutton、Maryannick Lamorlette、Zbigniew Matusiak
    DOI:10.1016/j.bmcl.2007.09.099
    日期:2007.12
    A new class of small-molecule GnRH antagonists, the thieno[2,3-b]pyrroles, was designed. Herein, the synthesis and structure-activity relationships are described. Substitution at the C4 position was investigated; during this study, it was observed that introducing piperazines and piperidines improved the physical properties of the compounds while retaining good in vitro potency. This exploration led to the discovery of amidopiperidines with improved pharmacokinetic properties. (c) 2007 Elsevier Ltd. All rights reserved.
  • Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists
    申请人:Harris Steven Craig
    公开号:US20070185106A1
    公开(公告)日:2007-08-09
    The invention relates to a group of novel thieno-pyrrole compounds of formula (I) wherein: R 1 , R 2 , R 3 , R 4 M, and R 5 are as defined in the specification, as inter alia, gonadotrophin releasing hormone antagonists. Novel compounds of formula (I) are also claimed. The invention also relates to pharmaceutical formulations of said compounds, methods of treatment using said compounds and to processes for the preparation of said compounds.
  • US7317010B2
    申请人:——
    公开号:US7317010B2
    公开(公告)日:2008-01-08
  • [EN] PYRROLE DERIVATIVES AS GONADOTROPIN RELEASING HORMONE (GNRH) ANTAGONISTS<br/>[FR] DERIVES DE PYRROLE UTILISES EN TANT QU'ANTAGONISTES DE L'HORMONE LIBERANT DE LA GONADOTROPHINE (GNRH)
    申请人:ASTRAZENECA AB
    公开号:WO2005079805A1
    公开(公告)日:2005-09-01
    The invention relates to a group of novel thieno-pyrrole compounds of formula (I) wherein: R1, R2, R3, R4 M, and R5 are as defined in the specification, as inter alia, gonadotrophin releasing hormone antagonists. Novel compounds of formula (I) are also claimed. The invention also relates to pharmaceutical formulations of said compounds, methods of treatment using said compounds and to processes for the preparation of said compounds.
    这项发明涉及一组新型噻吩-吡咯烯化合物,其化学式为(I),其中:R1、R2、R3、R4、M 和 R5 如规范中所定义,作为促性腺激素释放激素拮抗剂。化学式(I)的新型化合物也被要求。该发明还涉及所述化合物的药物配方、使用所述化合物的治疗方法以及所述化合物的制备方法。
查看更多